EphA5 Antibodies

Santa Cruz Biotechnology features a diverse variety of EphA5 monoclonal antibodies for research in understanding EphA5's role in various biological processes. EphA5 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EphA5 is a member of the Eph receptor family, which plays a significant role in cell signaling and communication, particularly in the development of the nervous system. EphA5 drives essential processes such as cell migration, adhesion, and the formation of synapses, making it fundamental for proper neuronal function and development. Research has shown that EphA5 expression changes can influence various diseases, including cancer and neurological disorders, highlighting its potential as a therapeutic target. Scientists can explore EphA5's molecular mechanisms through multiple experimental approaches using specific detection methods. Advanced research techniques enable detailed investigation of EphA5's cellular distribution, protein interactions, and signaling pathways. Understanding EphA5's functions continues to reveal new insights into cellular processes and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of EphA5's role in health and disease.